BriaCell to Present Four Poster Presentations at the 2026 AACR Annual Meeting

Core Insights - BriaCell Therapeutics Corp. announced that four abstracts have been accepted for poster presentation at the 2026 American Association for Cancer Research (AACR) Annual Meeting, scheduled for April 17th – 22nd in San Diego, CA [1][2] Company Overview - BriaCell is a clinical-stage biotechnology company focused on developing novel immunotherapies aimed at transforming cancer care [4] Research Highlights - The accepted abstracts will showcase research related to BriaCell's cellular immunotherapy platform, including the ongoing pivotal Phase 3 study of Bria-IMTᵀᴹ in combination with an immune checkpoint inhibitor (ClinicalTrials.gov identifier: NCT06072612) [2] - Additionally, the research will support Bria-OTS+ᵀᴹ, which is BriaCell's next-generation personalized off-the-shelf immunotherapy program [2] Presentation Details - Poster titles and presentation details will be available on March 17, 2026, at 4:30 PM ET, coinciding with the publication of the abstracts in the online Proceedings of AACR [3]